Coeliac disease is a chronic autoimmune enteropathy triggered by dietary Gluten exposure in individuals carrying HLA antigens-DQ2 (90-95%) or HLA antigens-DQ8 (5-10%) haplotypes. The disease is characterized by small intestinal Villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis, leading to malabsorption, nutritional deficiencies, and systemic inflammation. While genetic susceptibility is necessary, only 30-40% of HLA-DQ2/DQ8 carriers develop the disease, indicating critical environmental and microbiome modulation.
Imagine a gated border checkpoint where certain visitors (gluten peptides) are supposed to be screened and either granted safe passage or denied entry. In healthy individuals, the border guards (Tight junctions) keep most large molecules out, and those that do enter are checked by immigration officers (antigen-presenting cells) who generally stamp "harmless food" and let them pass.
In coeliac disease, the checkpoint has three fatal flaws. First, the genetic security system (HLA antigens-DQ2/DQ8) is specifically designed to raise red flags on gluten peptides β it's like having facial recognition software that treats wheat proteins as wanted criminals. Second, a rogue agent (Tissue transglutaminase) actively modifies these gluten peptides, making them look even MORE suspicious by adding negative charges (deamidation) β like a counterfeiter altering passports to trigger alarms. Third, once the alarm sounds, the border guards themselves get attacked and the gates blown open (Zonulin release, Intestinal permeability), allowing waves of bacteria, toxins, and incompletely digested food to flood across.
The military response is catastrophic and self-perpetuating. Soldiers (CD4+ T cells, IL-15-activated intraepithelial lymphocytes) don't just attack the invaders β they destroy the village to save it, burning down the finger-like watchtowers (villi) that line the border. Without these watchtowers, the checkpoint can't absorb nutrients, leading to starvation in the midst of plenty. Even worse, the immune system starts producing wanted posters (antibodies) not just for gluten but for the rogue agent (Tissue transglutaminase) itself β attacking your own security infrastructure in a classic autoimmune disease spiral.
The pathogenesis of coeliac disease involves coordinated innate and adaptive immune responses:
Stage 1: Barrier Breach and Peptide Modification
- Gluten proteins (Gliadin, glutenin, Hordeine, Secaline) resist complete degradation by gastric pepsin and pancreatic proteases due to high proline content
- Intact peptides (particularly 33-mer Ξ±-gliadin) cross intestinal epithelium via transcellular (increased endocytosis) or paracellular routes (via Zonulin-mediated Tight junctions opening)
- Tissue transglutaminase (tTG, a calcium-dependent enzyme) deamidates glutamine residues to glutamic acid, introducing negative charges
- Deamidated peptides have 100-1000Γ higher affinity for HLA antigens-DQ2 or HLA antigens-DQ8 binding grooves
Stage 2: Innate Immune Activation
- Gliadin p31-43 peptide triggers innate immunity independent of HLA
- IL-15 upregulation in epithelium β activation of intraepithelial lymphocytes (IELs)
- IELs express NKG2D receptors β recognize stress markers (MICA) on enterocytes
- IELs release granzyme B and perforin β enterocyte apoptosis β villous damage
Stage 3: Adaptive Immune Response
- Deamidated Gliadin peptides presented by HLA antigens-DQ2/DQ8 on dendritic cells
- CD4+ T cell activation in lamina propria β Th1 polarization
- Production of IFN-Ξ³ β activates macrophages and matrix metalloproteinases
- IL-15 + IFN-Ξ³ synergy β sustained inflammation
Stage 4: Autoantibody Production
- B cells recognize tTG-gliadin complexes (tTG presents gliadin to B cells)
- Plasma cells produce anti-tTG IgA (pathognomonic marker)
- Anti-endomysial antibodies (recognize tTG in tissue architecture)
- Anti-deamidated Gliadin peptide (DGP) IgA and IgG
Stage 5: Tissue Remodeling
- Chronic inflammation β Matrix metalloproteinases (MMPs) activation
- Villous atrophy: villi flatten, surface area reduced by 70-90%
- Crypt hyperplasia: compensatory stem cell proliferation
- Marsh classification: Type 0 (normal) β 3c (complete villous atrophy)
Perpetuation Mechanisms
graph TD
A[Gluten peptides cross epithelium] --> B[Tissue transglutaminase deamidation]
B --> C[Deamidated peptides bind HLA-DQ2/DQ8]
C --> D["CD4+ T cell activation"]
D --> E["IFN-Ξ³ and IL-15 production"]
E --> F[Intraepithelial lymphocyte activation]
F --> G[Enterocyte apoptosis]
G --> H[Villous atrophy]
A --> I[p31-43 peptide innate trigger]
I --> E
D --> J[B cell activation]
J --> K[Anti-tTG and anti-EMA antibodies]
E --> L[Zonulin upregulation]
L --> M[Increased intestinal permeability]
M --> A
H --> N[Malabsorption]
H --> O[Crypt hyperplasia]
Coeliac disease is the prototype autoimmune condition in cPNI, demonstrating how a specific environmental trigger (dietary antigen) interacts with genetic susceptibility and barrier dysfunction to create chronic disease. It exemplifies multiple core cPNI principles:
Evolutionary Mismatch: The 4-5 fold increase in prevalence over 50 years cannot be explained by genetics alone. Modern wheat contains higher gluten content due to selective breeding, while decreased microbiome diversity (due to antibiotics, C-sections, reduced breastfeeding) impairs Oral tolerance development. The "Old Friends Mechanism" suggests reduced microbial exposure in early life fails to educate immune tolerance.
Barrier-Immune Integration: Coeliac disease demonstrates the critical interdependence of gut barrier function and immune regulation. Zonulin levels >50 ng/mL indicate active barrier dysfunction. The lactulose-mannitol ratio >0.03 suggests both increased paracellular permeability (lactulose) and villous damage (reduced mannitol absorption). This is clinically testable and intervention-relevant.
Selfish Immune System: The immune response to Gluten reflects prioritization of pathogen defense over host welfare. The HLA antigens-DQ2 haplotype may have evolved to protect against specific pathogens, but creates Molecular Mimicry vulnerability with modern grain proteins. The system would rather destroy the gut than risk missing a potential threat.
Clinical Thresholds and Biomarkers:
- Anti-tTG IgA >10 U/mL (95% sensitivity, 98% specificity)
- Anti-endomysial antibodies (nearly 100% specific, gold standard)
- Anti-DGP IgG useful in IgA deficiency (present in 2-3% of coeliacs)
- Total IgA must be measured (rule out IgA deficiency)
- Marsh score on duodenal biopsy: 0 (normal) to 3c (complete atrophy)
- Genetic testing: HLA-DQ2.5 (most common), DQ2.2, DQ8 β negative predictive value 99% (rules out disease)
Intervention Implications:
- Strict Gluten-free diet is the only proven treatment β even trace amounts (<20 ppm) can perpetuate inflammation
- Address cross-reactivity: up to 50% react to Casein (alpha-casein and beta-casein share epitopes), corn (Zein), oats (Avenine in non-certified products)
- Microbiome restoration: Lactobacillus plantarum, Bifidobacterium infantis, and Faecalibacterium prausnitzii supplementation may reduce symptoms
- Barrier support: Zinc 30-50 mg/day, Vitamin D >50 ng/mL, Quercetin 500 mg BID (stabilizes Tight junctions)
- Nutrient repletion: Iron, B12, Folate, fat-soluble vitamins (A, D, E, K2) commonly deficient
- Monitor complications: annual bone density (risk of osteoporosis), thyroid function (30% develop Hashimoto's thyroiditis), screening for T-cell lymphoma if refractory
Prognosis: Villous atrophy typically reverses within 6-24 months on strict gluten-free diet, but antibodies may take 12-18 months to normalize. Refractory coeliac disease (Type I or II) occurs in <5% and carries significant lymphoma risk (40-60Γ general population).
- Prevalence approximately 1% globally, but only 10-20% are diagnosed (iceberg phenomenon)
- Diagnostic delay averages 6-10 years from symptom onset
- HLA antigens-DQ2.5 accounts for 90-95% of cases; DQ8 for 5-10%; 3-5% are DQ2.2
- 30-40% of European population carries DQ2 or DQ8, but only 1% develops disease
- Peak diagnostic ages: early childhood (2-5 years) and 4th-5th decades (bimodal)
- Classical presentation (diarrhea, weight loss, abdominal pain) now <30% of cases
- Non-classical presentations: iron-deficiency anemia (40%), osteoporosis (35%), neurological (10-25%), dermatitis herpetiformis (15-25%)
- Relative risk for first-degree relatives: 10-20Γ general population
- Untreated coeliac disease increases lymphoma risk 2-4Γ (mostly T-cell enteropathy-associated)
- Associated autoimmune conditions: Type 1 diabetes (5-10%), Hashimoto's thyroiditis (15-30%), Addison's disease, SjΓΆgren's syndrome
- Gluten threshold for villous damage: as low as 10-50 mg/day (equivalent to 1/100th of a slice of bread)
- Anti-tTG IgA correlates with degree of mucosal damage (Marsh score)
- Oats are tolerated by 95% if uncontaminated (certified gluten-free <20 ppm)
- 5-year adherence to gluten-free diet: 42-91% depending on support and education
- Gluten β primary dietary trigger containing Gliadin, glutenin, and other prolamines that initiate immune cascade
- Gliadin β specific gluten fraction with 33-mer peptide that is exceptionally resistant to proteolysis and highly immunogenic
- Intestinal permeability β both consequence and perpetuator of coeliac pathology; increased permeability allows antigen entry and bacterial translocation
- Zonulin β upregulated 3-10Γ in active coeliac disease, directly opens Tight junctions via PAR-2 and EGFR signaling
- Tight junctions β structural proteins (occludin, ZO-1, claudins) disrupted by IL-15, IFN-Ξ³, and TNF-Ξ±
- Tissue transglutaminase β enzyme that deamidates Gluten peptides AND serves as primary autoantigen target
- HLA antigens-DQ2 β MHC class II molecule with binding groove optimized for deamidated gluten peptides
- HLA antigens-DQ8 β alternative susceptibility allele, binds slightly different gluten epitopes than DQ2
- Villous atrophy β histological hallmark resulting from chronic IL-15 and IFN-Ξ³-mediated epithelial destruction
- IL-15 β master cytokine driving innate immunity, activates IELs independent of HLA presentation
- IFN-Ξ³ β Th1 cytokine that activates macrophages, increases MHC expression, and promotes tissue destruction
- Oral tolerance β failure of regulatory mechanisms (Tregs, TGF-beta, IL-10) allows pathological immune response to food antigen
- Microbiome β altered composition with reduced Bifidobacteria and Faecalibacterium prausnitzii impairs tolerance induction
- Dysbiosis β increased Enterobacteriaceae and Proteobacteria produce LPS that amplifies inflammation
- Antibodies β anti-tTG IgA, anti-endomysial, anti-DGP serve as diagnostic markers and correlate with disease activity
- Molecular Mimicry β Gliadin peptides share sequence homology with adenovirus E1b protein, potentially explaining why viral infection can trigger onset
- Autoimmune disease β coeliac exemplifies how environmental trigger + genetic susceptibility + barrier dysfunction = autoimmunity
- Antigen spreading β chronic inflammation leads to loss of tolerance to other food proteins (casein, corn, soy)
- Inflammation β sustained Th1-dominated response with elevated IL-6, TNF-Ξ±, IL-1Ξ² driving systemic effects
- Hashimoto's thyroiditis β co-occurs in 15-30% of coeliac patients, suggesting shared autoimmune susceptibility
- Type 1 diabetes β 5-10% prevalence in coeliac patients, both are HLA-DQ2/DQ8-associated autoimmune conditions
- Casein β cross-reactive protein due to Molecular Mimicry with gluten epitopes, affects 50% of coeliac patients
- Leaky gut β colloquial term for Intestinal permeability, central to coeliac pathogenesis and systemic symptom propagation
- Inflammatory bowel disease β shares features of mucosal inflammation and barrier dysfunction but distinct pathophysiology
- Malabsorption β consequence of reduced absorptive surface area (villous loss) leading to multiple nutrient deficiencies
- Iron β most common deficiency due to duodenal villous atrophy where iron absorption occurs
- B12 β deficiency occurs in 20-40% due to ileal involvement or bacterial overgrowth
- Vitamin D β deficiency in 60-70% due to fat malabsorption, exacerbates immune dysfunction
- Zinc β essential for Tight junctions maintenance and immune function; deficiency perpetuates barrier dysfunction